FDA Inspection 852996 — BioMarin Pharmaceutical, Inc.

BioMarin Pharmaceutical, Inc. — FEI 3004079983

The FDA completed an inspection of BioMarin Pharmaceutical, Inc. on September 24, 2013 in Novato, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 24, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Novato, CA (United States)

Additional Details

Sponsor, Contract Research Organization